These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Role of polyol-myoinositol metabolic changes in the pathogenesis of diabetic macro-angiopathy]. Fu MX; Qian RL Sheng Li Ke Xue Jin Zhan; 1990 Oct; 21(4):300-4. PubMed ID: 2100883 [No Abstract] [Full Text] [Related]
6. [Etiology and pathogenesis of diabetic angiopathies (a review of the literature)]. Efimov AS Vrach Delo; 1974 May; 5(0):7-12. PubMed ID: 4276277 [No Abstract] [Full Text] [Related]
7. [Quality of metabolic management and angiopathy in 180 long-term diabetics with at least 20 years duration of the disease]. Pense G; Panzram G; Pissarek D; Meinhold J; Müller W; Leder H; Kaselow D; Adolph W Schweiz Med Wochenschr; 1973 Aug; 103(32):1125-9. PubMed ID: 4755043 [No Abstract] [Full Text] [Related]
8. Vascular complications associated with diabetes mellitus. Spies ME Nurs Clin North Am; 1983 Dec; 18(4):721-33. PubMed ID: 6359070 [TBL] [Abstract][Full Text] [Related]
9. [Metabolic control and angiopathy in diabetes: vascular changes in animals with induced hyperglycemia, its relationship on human diabetes (author's transl)]. Studer PP Schweiz Rundsch Med Prax; 1979 Dec; 68(49):1630-6. PubMed ID: 397489 [No Abstract] [Full Text] [Related]
11. Do any changes similar to those in the basal membrane occur in other parts of the organism and could they be used for the early diagnosis of diabetes and diabetic angiopathy? Skrabalo Z Acta Diabetol Lat; 1971 Sep; 8 Suppl 1():378-90. PubMed ID: 5146910 [No Abstract] [Full Text] [Related]
12. [Structural-functional changes in biomembranes during complications of diabetes mellitus and their pharmacological correction]. Tat'ianenko LV; Bogdanov GN; Varfolomeev VN; Kotel'nikova RA; Shaposhnikova GI; Smirnov LD Vopr Med Khim; 1998; 44(6):551-8. PubMed ID: 10599141 [TBL] [Abstract][Full Text] [Related]
13. Diabetic angiopathy and neuropathy. A review with special reference to circulation in the extremities, the effect of hypophysectomy on capillary resistance and capillary permeability, functional abnormalities in early diabetes. Christensen NJ Acta Med Scand Suppl; 1972; 541():3-60. PubMed ID: 4571960 [No Abstract] [Full Text] [Related]
14. [Studies on phosphate clearance and TmPO4 in patients with diabetic angiopathies]. Lüdtke E Z Gesamte Inn Med; 1968 Aug; 23(15):Suppl:228-30. PubMed ID: 5678680 [No Abstract] [Full Text] [Related]
15. Pharmacokinetics of naproxen in healthy volunteers and in patients with diabetic microangiopathy. Calvo MV; Dominguez-Gil A; Miralles JM; de Pablo F Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):486-91. PubMed ID: 528094 [TBL] [Abstract][Full Text] [Related]
16. [Arterial hypertension in diabetes mellitus]. Tiengo A G Clin Med; 1990 Jan; 71(1):3-6, 10-6. PubMed ID: 2142112 [No Abstract] [Full Text] [Related]
17. [Certain biochemical peculiarities of diabetic angiopathies]. Paukman LI Ter Arkh; 1969 Sep; 41(9):82-4. PubMed ID: 5396459 [No Abstract] [Full Text] [Related]
18. [Vascular alterations and GH secretion in latent chemical diabetes]. Sgambato S; Carbone L; Bisesti V; Passariello N; Tesauro P; Varano R Boll Soc Ital Biol Sper; 1979 Feb; 55(3):279-85. PubMed ID: 399851 [TBL] [Abstract][Full Text] [Related]
19. [Hydroxyproline indicators before and after treatment of diabetic angiopathies]. Spesivtseva VG; Mamaeva GG; Starosel'tseva LK; Tulemisov EU; Bokaneva IA Ter Arkh; 1978; 50(1):93-7. PubMed ID: 635809 [No Abstract] [Full Text] [Related]
20. [Biochemistry of diabetic angiopathies]. Sato T Nihon Rinsho; 1977 Feb; 35(2):302-6. PubMed ID: 323545 [No Abstract] [Full Text] [Related] [Next] [New Search]